Management of postpartum hypertension
Article first published online: 11 JAN 2013
© 2013 Royal College of Obstetricians and Gynaecologists
The Obstetrician & Gynaecologist
Volume 15, Issue 1, pages 45–50, January 2013
How to Cite
Management of postpartum hypertension The Obstetrician & Gynaecologist2013;15:45–50., ,
- Issue published online: 11 JAN 2013
- Article first published online: 11 JAN 2013
- Manuscript Accepted: 2 APR 2012
- drug therapy;
- Appropriate treatment of postnatal hypertension is essential to prevent maternal morbidity and mortality from cerebral haemorrhage.
- Women with pre-eclampsia remain at risk of serious complications following delivery and should continue to be monitored as an inpatient for at least 72 hours.
- Compared with the antenatal period, a wider choice of antihypertensive agents are available to prescribe for the postnatal patient. An understanding of the basic pharmacology and risk–benefit profiles of each agent will facilitate patient-centred prescribing.
- Following discharge, the community team should be given clear guidelines for ongoing management of hypertension. A hospital postnatal appointment should be offered to discuss future pregnancy and cardiovascular risk.
- Review postpartum cardiovascular physiology following normal and hypertensive pregnancies.
- Demonstrate the principles of management and a suggested approach to management of postpartum hypertension based on NICE guidance.
- Discuss antihypertensive agents prescribed for women in the postpartum period.